Lipoprotein(a) and ultrasonographically determined early atherosclerotic changes in the carotid and femoral artery

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 2, 2003, Pages 374-379

  Sramek A ^a   Reiber, J H C ^a   Baak Pablo, R ^a   Sturkz, A ^a   Rosendaal, F R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Carotid artery; Femoral artery; Lipoprotein(a); Ultrasonography

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; BLOOD; CAROTID ARTERY; CAROTID ARTERY DISEASE; ECHOGRAPHY; FEMORAL ARTERY; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; ARTERIOSCLEROSIS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; FEMORAL ARTERY; HUMANS; LINEAR MODELS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS;

EID: 0141673305     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00064.x     Document Type: Article

References (42)

1. Berg K. A new serum type system in man - the LP system. Acta Pathol Microbiol Scand 1963; 59: 369-82.
2. Berg K, Dahlen G, Frick MH. Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet 1974; 6: 230-5.
3. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986; 59 (2): 199-204.
4. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758-65.
5. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540-4.
6. Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnagar D. Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease. Lancet 1988; 1 (8594): 1070-3.
7. Wald NJ, Law M, Watt HC et al. Apolipoproteins and ischaemic heart disease: implications for screening. Lancet 1994; 343: 75-9.
8. Valentine RJ, Grayburn PA, Vega GL, Grundy SM. Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med 1994; 154: 801-6.
9. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 1987; 330: 132-7.
10. Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein (a). Nature 1989; 339: 301-3.
11. Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem 1991; 266: 2459-65.
12. Loscalzo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein (a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990; 10: 240-5.
13. Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, Broze GJ, Simari RD. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 2001; 98: 2980-7.
14. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein (a). Science 1993; 260: 1655-8.
15. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein (a) mice. Nature 1994; 370: 460-2.
16. Schreiner PJ. Lipoprotein (a) as a risk factor for preclinical atherosclerotic disease in a biracial cohort: the Atherosclerosis Risk in Communities (ARIC) Study. Chem Phys Lipids 1994; 67-68: 405-10.
17. Schreiner PJ, Morrisett JD, Sharrett AR, Patsch W, Tyroler HA, Wu K, Heiss G. Lipoprotein[a] as a risk factor for preclinical atherosclerosis. Arterioscler Thromb 1993; 13 (6): 826-33.
18. Yamamoto M, Egusa G, Yamakido M. Carotid atherosclerosis and serum lipoprotein (a) concentrations in patients with NIDDM. Diabetes Care 1997; 20: 829-31.
19. Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E, Mair A. Lipoprotein (a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck Study. Stroke 1995; 26: 1582-7.
20. Schreiner PJ, Heiss G, Tyroler HA, Morrisett JD, Davis CE, Smith R. Race and gender differences in the association of Lp(a) with carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Biol 1996; 16: 471-8.
21. Baldassarre D, Tremoli E, Franceschini G, Michelagnoli S, Sirtori CR. Plasma lipoprotein (a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke 1996; 27: 1044-9.
22. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J, Salonen JT, Ehnholm C. Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994; 106: 9-19.
23. Markus HS, Kapadia R, Sherwood RA. Relationship between lipoprotein (a) and both stroke and carotid atheroma. Ann Clin Biochem 1997; 34: 360-5.
24. Lavrencic A, Kosmina B, Keber I, Videcnik V, Keber D. Carotid intimamedia thickness in young patients with familial hypercholesterolaemia. Heart 1996; 76: 321-5.
25. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein (a) and the risk of myocardial infarction. JAMA 1993; 270: 2195-9.
26. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-406.
27. Sramek A, Bosch JG, Reiber JH, Van Oostayen JA, Rosendaal FR. Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries. Invest Radiol 2000; 35: 699-706.
28. Koning G, Reiber JH, von Land CD, Loois G, van Meurs B. Advantages and limitations of two software calipers in quantitative coronary arteriography. Int J Card Imaging 1991; 7: 15-30.
29. Sosef MN, Bosch JG, van Oostayen J, Visser T, Reiber JH, Rosendaal FR. Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness. Thromb Haemost 1994; 72: 250-4.
30. Valentine RJ, Kaplan HS, Green R, Jacobsen DW, Myers SI, Clagett GP. Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis. J Vasc Surg 1996; 23: 53-61.
31. Lawn RM, Scanu AM. Lipoprotein (a). In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia: Lippincott-Raven Publishers, 1996: 151-61.
32. Utermann G. The mysteries of lipoprotein (a). Science 1989; 246: 904-10.
33. Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jurgens G. Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 1986; 17: 942-5.
34. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87 (Suppl. 3): II56-II65.
35. Giral P, Pithois-Merli I, Filitti V, Levenson J, Plainfosse MC, Mainardi C, Simon AC. Risk factors and early extracoronary atherosclerotic plaques detected by three-site ultrasound imaging in hypercholesterolemic men. Prevention Cardio-vasculaire en Medecine du Travail METRA Group. Arch Intern Med 1991; 151: 950-6.
36. Joensuu T, Salonen R,Winblad I, Korpela H, Salonen JT. Determinants of femoral and carotid artery atherosclerosis. J Intern Med 1994; 236: 79-84.
37. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991; 229: 225-31.
38. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134: 250-6.
39. Pauciullo P, Iannuzzi A, Sartorio R, Irace C, Covetti G, Di C, Rubba P. Increased intima-media thickness of the common carotid artery in hypercholesterolemic children. Arterioscler Thromb 1994; 14: 1075-9.
40. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study Arterioscler Thromb 1994; 14: 1885-91.
41. Burke GL, Evans GW, Riley WA, Sharrett AR, Howard G, Barnes RW, Rosamond W, Crow RS, Rautaharju PM, Heiss G. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk Communities (ARIC) Study. Stroke 1995; 26: 386-91.
42. Sramek A, Reiber JH, Gerrits WB, Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation 2001; 104: 762-7.